Back to News Research News from 2010

Research News From 2010

    29 December 2010

  1. [New!] Association of coxsackie virus infection and T lymphocyte subset changes with type 1 diabetes. Free full text available in PDF format.
  2. [New!] Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus.

    22 December 2010

  3. Birth order and childhood type 1 diabetes risk: a pooled analysis of 31 observational studies.
  4. Exenatide, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic beta-cell destruction induced by encephalomyocarditis virus.
  5. Left ventricular diastolic dysfunction in adolescents with type 1 diabetes reflects the long- but not short-term metabolic control.
  6. A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008.
  7. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025.
  8. Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis.
  9. Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans.
  10. Attenuation of Diabetes-Induced Cardiac Inflammation and Pathological Remodeling by Low-Dose Radiation.
  11. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.

    15 December 2010

  12. Analysis of pathogenesis of juvenile new onset diabetes.
  13. Cells reprogrammed to treat diabetes; Testes may be a source of insulin production. See also "Grow Your Own Transplant" May be Possible for Men with Type 1 Diabetes, Stem Cells Turned Into Complex, Functioning Intestinal Tissue in Lab, Stem Cells Used to Make Pancreas, Gut Cells and Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.

    8 December 2010

  14. Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial.
  15. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
  16. Efficacy Determinants of Subcutaneous Microdose Glucagon during Closed-Loop Control.
  17. Factors influencing the effectiveness of glucagon for preventing hypoglycemia.

    1 December 2010

  18. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes The Allegheny County Type 1 Diabetes Registry. See also Type 1 Diabetes Death Rate is Falling, But Not Fast Enough.
  19. Preclinical arterial disease in patients with type 1 diabetes without other major cardiovascular risk factors or macro-microvascular disease.
  20. Danish children born 1981-2002 with GAD65 and IA-2 autoantibodies at birth had an increased risk to develop type 1 diabetes before 2004.
  21. Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited.
  22. Detection of nocturnal hypoglycemic episodes using EEG signals.

    24 November 2010

  23. Genome-Wide Analysis of Copy Number Variation in Type 1 Diabetes. Free full text available in HTML and PDF formats.
  24. Insulin-producing cells from human pancreatic islet-derived progenitor cells following transplantation in mice. Free full text available in PDF format.
  25. Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs. Free full text available in HTML and PDF formats.
  26. Short-Term Environmental Enrichment Enhances Adult Neurogenesis, Vascular Network and Dendritic Complexity in the Hippocampus of Type 1 Diabetic Mice. Free full text available in HTML and PDF formats.

    17 November 2010

  27. Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity. See also Infant Formula May Help Prevent Type I Diabetes.
  28. Spontaneous In Vivo Differentiation of Embryonic Stem Cell-Derived Pancreatic Endoderm-Like Cells Corrects Hyperglycemia in Diabetic Mice.

    10 November 2010

  29. Beta cell function during rapamycin monotherapy in long-term type 1 diabetes.
  30. Production of Functional Glucagon-Secreting Alpha Cells from Human Embryonic Stem Cells.
  31. GAD-alum treatment induces GAD(65)-specific CD4(+)CD25(high)FOXP3(+) cells in type 1 diabetic patients.

    3 November 2010

  32. A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen Supply.
  33. Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade.
  34. High connectivity between reduced cortical thickness and disrupted white matter tracts in longstanding type 1 diabetes.
  35. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-D-glucosaminidase.

    27 October 2010

  36. Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets.
  37. Circulating Reg1-alpha Proteins and Autoantibodies to Reg1-alpha Proteins as Biomarkers of beta-Cell Regeneration and Damage in Type 1 Diabetes..

    20 October 2010

  38. Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes.
  39. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. Free full text available in HTML and PDF formats.
  40. Reduction in the Incidence of Type 2-Diabetes with the Mediterranean Diet: Results of the PREDIMED-Reus Nutrition Intervention Randomized Trial.

    13 October 2010

  41. Low zinc in drinking water is associated with the risk of type 1 diabetes in children.
  42. Prevention of type 1 diabetes: today and tomorrow.
  43. Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green "Traffic" Lights Using Continuous Glucose Monitoring and Insulin Pump Data.
  44. Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose.
  45. High levels of education are associated with an increased risk of latent autoimmune diabetes in adults — Results from the Nord-Trøndelag Health Study.
  46. Repeated episodes of hypoglycemia as a potential aggravating factor for preclinical atherosclerosis in subjects with T1D.
  47. Risk of Cardiovascular Disease Events in Patients with Type 2 Diabetes Prescribed the GLP-1 Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLink™ Database.

    6 October 2010

  48. Use of technology to potentially preserve C-Peptide in type 1 diabetes mellitus.
  49. The pathway to the closed-loop artificial pancreas: research and commercial perspectives.
  50. Continuous Glucose Monitoring in Subjects with Type 1 Diabetes: Improvement in Accuracy by Correcting for Background Current.
  51. Automatic Bolus and Adaptive Basal Algorithm for the Artificial Pancreatic beta-Cell.
  52. The use of technology to reduce hypoglycemia.

    29 September 2010

  53. Extended Family History of Diabetes and Autoimmune Diseases in Children With and Without Type 1 Diabetes.
  54. Oxidative stress and autonomic nerve function in early type 1 diabetes.
  55. The rising incidence of type 1 diabetes mellitus and the role of environmental factors--three decade experience in a primary care health center in Saudi Arabia.
  56. Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies - Results from The Hvidoere Study Group.
  57. EASD: The Gut Takes Bigger Role in Diabetes Research.
  58. Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist. Free full text available in HTML and PDF formats.
  59. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice.
  60. Dietary iron intake in the first 4 months of infancy and the development of type 1 diabetes: a pilot study. Free full text available in PDF format.

    22 September 2010

  61. Enterovirus Infection and Progression from Islet Autoimmunity to Type 1 Diabetes: The Diabetes and Autoimmunity Study in the Young (DAISY).
  62. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat.
  63. Maternal dietary n-6/n-3 fatty acid ratio affects type 1 diabetes development in the offspring of NOD mice.
  64. Performance of Glycated Hemoglobin for the Classification and Prediction of Diabetes.

    8 September 2010

  65. Evaluation of preserved insulin secretion in children and adolescents with type 1 diabetes.
  66. Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: Role of metabolic reprogramming in counterregulatory failure.
  67. Enteroviral pathogenesis of type 1 diabetes.
  68. No Protective Effect of Calcitriol on beta-Cell Function in Recent-Onset Type 1 Diabetes The IMDIAB XIII trial.

    1 September 2010

  69. Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses.
  70. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort.
  71. Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation.
  72. Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes.
  73. In vivo study of a polymeric glucose-sensitive insulin delivery system using a rat model.
  74. Survival of Patients With Type 1 Diabetes Receiving Renal Replacement Therapy in 1980–2007.
  75. Modified gold nanoparticle vectors: A biocompatible intracellular delivery system for pancreatic islet cell transplantation.

    25 August 2010

  76. Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.
  77. Human cord blood stem cells and the journey to a cure for type 1 diabetes.
  78. Diet with a low n-6/n-3 essential fatty acid ratio when started immediately after the onset of overt diabetes prolongs survival of type 1 diabetes model NOD mice.
  79. Failure of Multiple Therapies in the Treatment of a Type 1 Diabetes Patient with an Insulin Allergy: A Case Report.

    18 August 2010

  80. Residual Insulin Production and Pancreatic {beta} Cell Turnover after 50 Years of Diabetes: Joslin Medalist Study.
  81. Environmental, maternal influences alter type 1 diabetes risk in children.
  82. Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats.
  83. Butyrate and Type 1 Diabetes Mellitus: Can We Fix the Intestinal Leak?

    11 August 2010

  84. Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses.

    4 August 2010

  85. Function of an Implanted Tissue Glucose Sensor for More than 1 Year in Animals. See also Implanted Glucose Sensor Works for More than One Year and S.D. company hopes monitor will revolutionize diabetes care.
  86. Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events.
  87. Postprandial Glycemic Excursions with the Use of a Closed-Loop Platform in Subjects with Type 1 Diabetes: A Pilot Study.
  88. Albuminuria and VEGF as early markers of cardiovascular disturbances in young type 1 diabetic patients.
  89. Environmental Factors Associated With Childhood-Onset Type 1 Diabetes Mellitus - An Exploration of the Hygiene and Overload Hypotheses. See also Environment Influences Type 1 Diabetes Risk.
  90. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
  91. Resveratrol Shows Vasoprotective Effect Reducing Oxidative Stress Without Affecting Metabolic Disturbances in Insulin-dependent Diabetes of Rabbits. (See also Resveratrol at Wikipedia.)

    28 July 2010

  92. Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle: Establishment of a Vascular System Similar to that in Native Islets.
  93. Anticipating the next meal using meal behavioral profiles: A hybrid model-based stochastic predictive control algorithm for T1DM.
  94. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association?

    21 July 2010

  95. Estimating the cost of type 1 diabetes in the u.s.: a propensity score matching method. Free full text available in HTML and PDF formats (link in HTML full text).
  96. Early Life Disease Programming during the Preconception and Prenatal Period: Making the Link between Stressful Life Events and Type-1 Diabetes. Free full text available in HTML and PDF formats (link in HTML full text).
  97. Genetic testing of newborns for type 1 diabetes susceptibility: a prospective cohort study on effects on maternal mental health.
  98. Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age.
  99. A health-economic analysis of porcine islet xenotransplantation.
  100. Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review.
  101. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden.

    14 July 2010

  102. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic {beta}-like cells. Free full text available in PDF format.
  103. Toward defining the autoimmune microbiome for type 1 diabetes.
  104. Number of autoantibodies and HLA Genotype, more than high titers of glutamic acid decarboxylase autoantibodies (GADA65Ab), predict insulin dependence in latent autoimmune diabetes of adults (LADA).
  105. The association of variable number of tandem repeats of the insulin gene with susceptibility to type 1 diabetes among Korean subjects.

    7 July 2010

  106. A nested case-control study of intrauterine exposure to persistent organochlorine pollutants in relation to risk of type 1 diabetes. Free full text available in HTML and PDF formats.
  107. Generation of insulin-producing cells from gnotobiotic porcine skin-derived stem cells.
  108. Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy.
  109. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden.

    30 June 2010

  110. ADA: 'Artificial Pancreas' Reins in Glucose After Feast.
  111. FDA Approves Trial For Type 1 Diabetes Treatment By Ben-Gurion U. And U. Colorado.
  112. Sleep Restriction For One Week Reduces Insulin Sensitivity In Healthy Men.

    23 June 2010

  113. Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis.
  114. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV).
  115. Age-period-cohort Analysis Of 1990-2003 Incidence Time Trends Of Childhood Diabetes In Italy: The RIDI Study.
  116. Genetic Defect Tied to Autoimmune Diseases.
  117. Insulin peptide may point to a solution for type 1 diabetes.
  118. Gene therapy reverses type 1 diabetes in mice.

    16 June 2010

  119. Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes.
  120. Role of C-peptide in the pathogenesis of diabetic nephropathy.
  121. Serum C peptide level and renal function in diabetes mellitus. Free full text available in HTML format.
  122. Endothelial Abnormalities in Adolescents with Type 1 Diabetes: A Biomarker for Vascular Sequelae?
  123. Diagnosing silent cardiac dysautonomia via ambulatory blood pressure monitoring: early diagnosis shown by the lack of heart rate circadian rhythm in type 1 diabetes mellitus.
  124. Population genetics of IFIH1: ancient population structure, local selection and implications for susceptibility to type 1 diabetes.
  125. Brain Insulin Action Regulates Hypothalamic Glucose Sensing and the Counterregulatory Response to Hypoglycemia.

    9 June 2010

  126. Patients' Perception and Future Acceptance of an Artificial Pancreas.
  127. Early Signs Of Atherosclerosis In Diabetic Children On Intensive Insulin Treatment: A Population-based Study.
  128. Time for testing incretin therapies in early type 1 diabetes?
  129. Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1.
  130. Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes.
  131. Assessment of Islet Quality Following International Shipping of more than 10,000 Km.

    2 June 2010

  132. Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring - A safety net for the artificial pancreas.
  133. Prediction of Type 1 Diabetes in the General Population.
  134. Patient and Parent Views on a Web 2.0 Diabetes Portal-the Management Tool, the Generator, and the Gatekeeper: Qualitative Study.
  135. Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case-control study. Free full text available in HTML and PDF formats.

    26 May 2010

  136. Study links viral infection to juvenile diabetes.
  137. Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison.
  138. The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.
  139. The immunotherapeutic potential of dendritic cells in type 1 diabetes.
  140. Lipoatrophy Induced by Subcutaneous Insulin Infusion: Ultrastructural Analysis and Gene Expression Profiling.

    19 May 2010

  141. Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis.
  142. Co-occurrence of allergic sensitization and type 1 diabetes.
  143. Current Status of Xenotransplantation and Prospects for Clinical Application. Free full text available in HTML and PDF formats.
  144. Cerebral structural and functional changes in type 1 diabetes.

    12 May 2010

  145. Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus.
  146. Comparison of Urinary Albumin-Creatinine Ratio and Albumin Excretion Rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
  147. Decreased Contrast Sensitivity in Children and Adolescents with Type 1 Diabetes Mellitus.

    5 May 2010

  148. Incorporating Type 1 Diabetes Prevention Into Clinical Practice.
  149. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
  150. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
  151. Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet.
  152. Enteroviruses in the pathogenesis of type 1 diabetes.
  153. Biochemical markers of bone cell activity in children with type 1 diabetes mellitus.
  154. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years.

    28 April 2010

  155. Immunotherapy of type 1 diabetes: where are we and where should we be going?
  156. Regional adiposity and risk for coronary artery disease in type 1 diabetes: Does having greater amounts of gluteal-femoral adiposity lower the risk?
  157. Age is a Determinant of Acute Hemodynamic Responses to Hyperglycemia and Angiotensin II in Humans with Uncomplicated Type 1 Diabetes Mellitus.
  158. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
  159. Decrease in {beta}-Cell Proliferation Precedes Apoptosis during Diabetes Development in Bio-Breeding/Worcester Rat: Beneficial Role of Exendin-4.
  160. The Development and Progression of Renal Insufficiency with and without Albuminuria in Adults with Type 1 Diabetes Mellitus in the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
  161. Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Blind, Placebo-Controlled, Crossover, 32 Weeks Study.
  162. 21 April 2010

  163. A bihormonal closed-loop artificial pancreas for type 1 diabetes. See also Novel Artificial Pancreas System Using Two Hormones Successfully Controls Blood Sugar Levels In Type 1 Diabetes Patients and Research offers promise for diabetics. To learn more, see Using mathematics to treat diabetes ... five minutes at a time (specifically the Publications section).
  164. Infant feeding and the risk of type 1 diabetes.
  165. Monocyte Gene-Expression Profiles Associated With Childhood-Onset Type 1 Diabetes and Disease Risk: A Study of Identical Twins.
  166. Quantification and 3-D imaging of the insulitis-induced destruction of beta-cells in murine Type 1 Diabetes.
  167. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.
  168. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA(1c): the A1C-Derived Average Glucose (ADAG) study.
  169. 14 April 2010

  170. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
  171. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring.
  172. Inflammatory Markers Are Increased in Youth with Type 1 Diabetes: The SEARCH Case-Control Study.
  173. Insulin Resistance is Associated with Microangiopathy in Type 1 Diabetic Patients Treated with Intensive Insulin Therapy from the Onset of Disease.
  174. HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus.
  175. Incidence trends of childhood type 1 diabetes in eastern Saudi Arabia.
  176. 7 April 2010

  177. C-Peptide as a Therapeutic Tool in Diabetic Nephropathy.
  178. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes.
  179. No Effect of the 1-alpha,25-dihydroxyvitamin D3 on Beta Cell Residual Function and Insulin Requirement in Adults with New-Onset Type 1 Diabetes.
  180. Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and diabetic nephropathy – cohort analysis of the Diabetes Control and Complications Trial (DCCT).

    31 March 2010

  181. In light of the suggested correlation between vitamin D deficiency and increased risk for type 1 diabetes, Adherence to Vitamin D Recommendations Among US Infants and Widespread Vitamin D Deficiency in Urban Massachusetts Newborns and Their Mothers are noteworthy.
  182. Infant feeding and the risk of type 1 diabetes.
  183. Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies.
  184. Lack of effect of short-term treatment with Amlodipine and Lisinopril on retinal autoregulation in normotensive patients with type 1 diabetes and mild diabetic retinopathy.
  185. Leptin therapy in insulin-deficient type I diabetes. Free full text available in HTML and PDF formats. See also Texas Researcher Poised to Test Leptin as a Replacement for Insulin Among Type 1s.

    24 March 2010

  186. Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes.
  187. Vitamin D and Diabetes.
  188. Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes.
  189. High-Normal Serum Uric Acid Increases Risk of Early Declining Renal Function In Type 1 Diabetes: Results of 6-year Follow-up.
  190. Do statins delay the incidence of ESRD in diabetic patients with moderate CKD?

    17 March 2010

  191. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.
  192. Continuous Glucose Monitoring Reveals Associations of Glucose Levels with QT Interval Length.
  193. Successes and disappointments with clinical islet transplantation.
  194. The Programmable Cell of Monocytic Origin (PCMO): A Potential Adult Stem/Progenitor Cell Source for the Generation of Islet Cells.
  195. The Type 1 Diabetes - HLA Susceptibility Interactome - Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes. Free full text available in HTML and PDF formats (see HTML full text for PDF link).
  196. Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice.

    10 March 2010

  197. Association of A1c Levels with Vitamin D Status in U.S. Adults: Data from the National Health and Nutrition Examination Survey.
  198. Feature Article: Leptin therapy in insulin-deficient type I diabetes.
  199. Treatment with insulin glargine (Lantus((R))) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells.

    3 March 2010

  200. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
  201. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort.
  202. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.

    24 February 2010

  203. Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus.
  204. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
  205. Stem cell therapy for type 1 diabetes mellitus.
  206. Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy.
  207. Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes.
  208. Effectiveness of Intravenous Infusion Algorithms for Glucose Control in Diabetic Patients Using Different Simulation Models.
  209. Clinical Evaluation of a Noninvasive Alarm System for Nocturnal Hypoglycemia.

    17 February 2010

  210. MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus.
  211. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus.
  212. Exploring self-management characteristics in youths with type 1 diabetes mellitus: does membership in a glycemic control category matter?
  213. The impact of vitamin D deficiency on diabetes and cardiovascular risk.

    10 February 2010

  214. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. See also Early Artificial Pancreas Trials Show Benefits for Kids, Teenagers with Diabetes While Sleeping Overnight and Insulin Study Could Lead to New Dosage Devices.
  215. Space-time clustering analyses of type 1 diabetes in children from north-east England: support for an infectious aetiology?
  216. PSECMAC Intelligent Insulin Schedule for Diabetic Blood Glucose Management Under Nonmeal Announcement.
  217. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. See also Researchers Discover Protein that Triggers Islet Cell Rejection.

    3 February 2010

  218. A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes.
  219. Polysaccharide Multilayer Nanoencapsulation of Insulin-Producing beta-Cells Grown as Pseudoislets for Potential Cellular Delivery of Insulin.

    27 January 2010

  220. Glucose Levels at the Site of Subcutaneous Insulin Administration and Their Relationship to Plasma Levels.
  221. Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.
  222. Teplizumab therapy for type 1 diabetes.
  223. Aluminum Gallium Nitride (GaN)/GaN High Electron Mobility Transistor-Based Sensors for Glucose Detection in Exhaled Breath Condensate. See also Breath-based glucose sensor developed (and why it may never make it to market).

    20 January 2010

  224. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset.
  225. High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus.
  226. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: Findings from the Coronary Artery Calcification in Type 1 Diabetes study.
  227. Coronary vasoreactivity is not altered in young people with type 1 diabetes.
  228. Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes-The brain as a biosensor.
  229. Immunity to poliovirus after vaccination of children with type 1 diabetes mellitus and rheumatic diseases.

    13 January 2010

  230. Dimorphic histopathology of long-standing childhood-onset diabetes.
  231. Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus.
  232. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data.
  233. Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus.
  234. Helminthic therapy: using worms to treat immune-mediated disease.
  235. Hypoglycemia unawareness in patients with type 1 diabetes: pilot study of naltrexone therapy.

    6 January 2010

  236. Results of ITN insulin B-chain study for type 1 diabetes published summarizes Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy, previously reported.
  237. Anti-inflammatory properties of C-Peptide.
  238. C-Peptide: the missing link in diabetic nephropathy?
  239. The beneficial effects of C-Peptide on diabetic polyneuropathy.
  240. C-Peptide and its intracellular signaling.
  241. A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.
  242. Molecular effects of C-Peptide in microvascular blood flow regulation.
  243. C-Peptide in the vessel wall.
  244. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.
  245. Pancreatic acellular matrix supports islet survival and function in a synthetic tubular device: in vitro and in vivo studies.
  246. The in vivo performance of bioartificial pancreas in bone marrow cavity: A case report of a spontaneous diabetic feline.
  247. Skeletal Muscle Metabolism in the Pathology and Treatment of Type 1 Diabetes.
  248. Cardiovascular autonomic neuropathy, HDL-cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.
  249. Ductal Origin Hypothesis of Pancreatic Regeneration under Attack. Free full text available in PDF format.
  250. Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene. Free full text available in HTML and PDF formats. See also Leptin-Linked Gene Reverses [Type 2] Diabetes in Mice.

[ Current Research News | News from 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

  Back to News Return to the Top of This Page

Last Updated: Thursday January 01, 2015 15:29:01
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.